OncoDaily’s Post

Understanding Bladder Cancer Stages: A Comprehensive Guide. Bladder cancer, though a serious condition, is often highly treatable, especially when detected early. In our latest blog authored by Dr. Srivathsan Ramani delves deep into the different types and stages of bladder cancer, providing valuable insights into diagnosis, treatment options, and patient prognosis. At Apollo Proton Cancer Centre (APCC), we emphasize the importance of early detection and a multidisciplinary approach to treatment. Our dedicated team of urologists, oncologists, and radiation oncologists work together to create personalized treatment plans tailored to each patient's needs. Read the full blog here: [https://lnkd.in/gJXz6TMJ] Join us in spreading awareness and knowledge about bladder cancer. Together, we can make a difference! #WinningOverCancer #BladderCancer #CancerAwareness #Healthcare #Oncology #ApolloProtonCancerCentre #APCC

Interested in the latest insights from oncologists ahead of #ASCO24? 🚀 Check out perspectives on this year's conference from the front lines of cancer care in our latest blog post: https://lnkd.in/eYupPznU #ASCO24 #OncologyInsights #HealthcareMarketResearch

Dana-Farber Cancer InstituteAlicia SimonsShelby Janner #PalliativeCare #SupportiveCare #Oncology #CancerCare #BreastCancerAwareness #QualityOfLife #PatientCare #CompassionateCare #HealthcareInnovationLaura Carfang Surviving Breast Cancer I recently joined the Breast Cancer Conversations podcast to talk about the role of palliative and supportive care in cancer treatment. Palliative care isn’t just about end-of-life support. It’s a way to improve the quality of life for patients and their families, starting early in treatment. This approach can make a real difference in outcomes and experiences. During the episode, I shared some of what I’ve learned over my years at Dana-Farber Cancer Institute and through my work with oncology teams.. You can listen to the episode here: https://lnkd.in/d9UGnBaH

Our patient focused work discussing the complexities of clinical trials and what they mean in cancer care! - Aakash Desai, MD, MPH O'Neal Comprehensive Cancer Center at UAB UAB Medicine JAMA Fawzi Abu Rous Eric Singhi https://lnkd.in/dS-THBbi #Cancer #OncoDaily #Oncology #PatientCare #ClinicalTrials #CancerCare

In this episode of Making the Rounds, we discuss a topic that's crucial for both health care providers and patients – breast cancer. We talk through innovative treatments, updated screening guidelines, how to identify high-risk patients, and provide a deeper understanding of inflammatory breast cancer and how it's diagnosed. 🎙️ Watch now: https://bit.ly/4hqpSks You'll hear from Hung Khong, MD, a medical oncologist specializing in breast cancer, section chief of medical oncology and co-director of the Comprehensive Breast Cancer Program at Banner MD Anderson Cancer Center. To learn more about this topic or other oncology-related services provided at Banner MD Anderson, please visit https://bit.ly/3uJSjSL #oncology #breastcancer #endcancer #podcast

Last Autumn, Jo Taylor founder of After Breast Cancer Diagnosis and METUPUK and Eva Schumacher from Mamma Mia, an online German cancer magazine, (Eva is a patient living with MBC), were asked to be involved in a campaign about “platitudes”. What you DON’T want to hear and what you DO want to hear from family members, friends, colleagues and even random strangers, when you are living with an incurable disease. The results of this work have been presented in a poster session at ESMO (European Society for Medical Oncology) Breast 248P this week and has won the best poster award! The findings were based on a survey of 249 people living with metastatic breast cancer. This report was initiated and funded by Seagen now part of Pfizer. You can read the poster via link here https://buff.ly/4aFiKwh #MetastaticMay #costofliving #severitymodifier #METUPUK #DarkerPink #BusyLivingWithMets #IAmThe31 #waitingroomfeet #BCAM #BreastCancer #BreastCancerCommunity #BreastCancerJourney #BreastCancerSupport #DyingForACure #EarlyDetectionSavesLives #MetastaticBreastCancerAwareness #SecondaryBreastCancer #SecondarySisters #Stage4NeedsMore #StageIVNeedsMore

🔛 Have you read our latest newsletter yet? The feedback has been amazing so far, and we can’t wait to hear your thoughts! 🙌 As a reminder, we recently launched our second-year newsletter, highlighting our key achievements in revolutionising breast cancer treatment. This edition showcases our exciting progress, including the launch of an international study on our #AI driven radiomics tools 🧠 👉 To access it and for additional insights, check out our next article on: https://lnkd.in/dPrk8MNk #HorizonEU #EUFunded #BreastCancer #Newsletter

Listen to Dr. Isaac Garcia-Murillas from The Institute of Cancer Research and Dr. Richard Chen, CMO and EVP of R&D, Personalis, discuss a study with leading world experts in breast cancer (Dr. Nicholas Turner from The Royal Marsden NHS Foundation Trust) highlighting how NeXT Personal® was able to detect the smallest traces of cancer in the blood (ctDNA) a median of ~15 months ahead of scans in a cohort of 78 patients with breast cancer (all subtypes).   In this robust study, median follow-up time was ~6 years and researchers analyzed 619 plasma samples (a median of 8 samples per patient).   Learn about the results of ultra-sensitive MRD testing with NeXT Personal in Breast Cancer. #PrecisionOncology #LiquidBiopsy #MRD #ctDNA #BreastCancer #BreastCancerAwarenessMonth

🎗️ The Vital Role of Study Coordinators in Breast Cancer Trials 🎗️ As we observe Breast Cancer Awareness Month, it’s important to recognize the patients and survivors but also the incredible teams behind life-saving clinical research. At the heart of every successful breast cancer trial are the investigators but also the Study Coordinator—a key player ensuring that research runs smoothly and patients receive the care and support they need. In breast cancer trials, where precision is crucial and patient well-being is paramount, Study Coordinators manage the complex logistics of recruitment, data collection, and patient follow-up. They ensure that every participant is supported, every protocol is followed, and every detail is documented—all while fostering an environment of compassion and care. #BreastCancerAwarenessMonth #BreastCancerAwareness #PinkOctober #ClinicalTrials #StudyCoordinators #BreastCancerResearch #OncologyResearch #HealthcareHeroes